Covid-19: 161 Omicron cases reported in India, says Mansukh Mandaviya

India has reported 161 cases of new coronavirus variant Omicron, Union Health Minister Mansukh Mandaviya said

Mansukh L. Mandaviya
ANI General News
2 min read Last Updated : Dec 20 2021 | 4:54 PM IST

India has reported 161 cases of new coronavirus variant Omicron, Union Health Minister Mansukh Mandaviya said on Monday.

"As of now, India has 161 Omicron cases...We are monitoring the situation daily with experts," the minister told Rajya Sabha while replying to debate on the COVID-19 situation.

He said the government has taken steps to deal with situation if the virus spreads.

"With our experience during the first and second waves, to ensure that we don't face problems if variant spreads, we have arranged a buffer stock of important medicines."

He said the states and union territories have adequate quantity of vaccines against COVID-19 for vaccination drives, adding that the country's vaccine manufacturing capacity has also increased.

"Today all states and UTs have adequate quantity of vaccines, 17 crore doses available with them. Our manufacturing capacity has increased. Today India has capacity to manufacture 31 crore doses of vaccine per month. In next two months, it'll further rise to 45 crore doses per month," the minister said.

"Under PM Modi's leadership, with the efforts of our healthcare workers, 88 per cent of first doses of the COVID vaccine have been administered and 58 per cent of second doses administered so far. The majority of the population in India is vaccinated today," he added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Dec 20 2021 | 4:54 PM IST

Next Story